ALEXION PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 76179
 
  
 
C07K PEPTIDES 7663
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 30137
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 16190
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1287
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 594
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 5120
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 346
 
  
 
G06F ELECTRIC DIGITAL DATA PROCESSING 3444
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS246

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0072,769 VIRUS FILTRATIONMar 23, 16Mar 15, 18[C07K, B01D]
2018/0074,077 A METHOD FOR MEASURING THE PROTEASE ACTIVITY OF FACTOR D OF THE ALTERNATIVE COMPLEMENT PATHWAYMar 29, 16Mar 15, 18[C12N, G01N]
2017/0369,562 METHODS FOR TREATING COMPLEMENT-ASSOCIATED DISORDERSSep 11, 17Dec 28, 17[A61K, C07K]
2017/0342,139 Methods for Treatment of Refractory Generalized Myasthenia GravisMay 15, 17Nov 30, 17[A61K, C07K, A61M]
2017/0266,264 TRUNCATED LYSOSOMAL ACID LIPASEDec 21, 16Sep 21, 17[A61K, C12N]
2017/0267,751 PROLONGATION OF SURVIVAL OF AN ALLOGRAFT BY INHIBITING COMPLEMENT ACTIVITYMar 31, 17Sep 21, 17[C07K]
2017/0269,102 ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) BIOMARKER PROTEINSApr 14, 17Sep 21, 17[A61K, G01N, C07K]
2017/0175,094 COMPOSITIONS AND METHODS FOR TREATING CRANIOSYNOSTOSISJul 10, 15Jun 22, 17[C12N]
2017/0073,399 RECOMBINANT GLYCOSYLATED ECULIZUMAB AND ECULIZUMAB VARIANTSSep 09, 16Mar 16, 17[C12N, C07K]
2017/0015,740 METHODS FOR TREATING COMPLEMENT-ASSOCIATED DISORDERSSep 30, 16Jan 19, 17[C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9908932 Methods of shifting an isoelectric profile of a protein product and uses thereofOct 13, 15Mar 06, 18[C12P, G01N, C07K]
9862767 Therapeutic methods using anti-CD200 antibodiesJun 15, 15Jan 09, 18[A61K, C07K]
9803005 Humaneered anti-factor B antibodyMay 20, 13Oct 31, 17[A61K, C07K]
9803007 Anti-C5 antibodies having improved pharmacokineticsApr 20, 17Oct 31, 17[A61K, C07K]
9771418 Methods for treating complement-associated disordersAug 22, 16Sep 26, 17[A61K, C07K]
9732149 Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complementOct 03, 16Aug 15, 17[A61K, C07K]
9725504 Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complementSep 09, 16Aug 08, 17[A61K, C07K]
9718880 Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complementMay 06, 16Aug 01, 17[A61K, C07K]
9663574 Anti-C5 antibodies having improved pharmacokineticsMay 20, 16May 30, 17[A61K, C07K]
9658236 Atypical hemolytic uremic syndrome (aHUS) biomarker proteinsOct 06, 16May 23, 17[A61K, G01N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0086,431 GERMLINE TRANSMISSION OF CHICKEN PRIMORDIAL GERM CELLS (PGCS)AbandonedSep 23, 16Mar 30, 17[C12N, A01K, C07K]
2016/0355,580 METHODS FOR TREATING COMPLEMENT-ASSOCIATED DISORDERSAbandonedAug 22, 16Dec 08, 16[C07K]
2016/0319,004 METHODS AND COMPOSITIONS FOR TREATING COMPLEMENT-ASSOCIATED DISORDERSAbandonedMay 06, 16Nov 03, 16[A61K, C07K]
2015/0282,503 Producing Therapeutic ProteinsAbandonedApr 01, 15Oct 08, 15[A23J, A01K, B01D]
2015/0247,849 SCREENING ASSAYS FOR COMPLEMENT COMPONENT C5 ANTAGONISTSAbandonedSep 20, 13Sep 03, 15[G01N]
2015/0174,243 COMPOSITIONS COMPRISING A COMPLEMENT INHIBITOR AND AN INTERFERON ALPHA INHIBITORAbandonedMar 04, 15Jun 25, 15[A61K]
2015/0098,933 TRUNCATED LYSOSOMAL ACID LIPASEAbandonedMar 01, 13Apr 09, 15[A61K, C12N]
2015/0079,613 ATYPICAL HEMOLYTIC UREMIC SYNDROME BIOMARKER PROTEINSAbandonedAug 06, 14Mar 19, 15[G01N]
2015/0030,582 Lysosomal Storage Disease EnzymeAbandonedSep 19, 14Jan 29, 15[A61K]
2014/0298,503 Glycosylation in AviansAbandonedApr 01, 13Oct 02, 14[A01K]
2014/0289,879 Production of Transgenic Avians Using Improved Retroviral VectorsAbandonedFeb 28, 14Sep 25, 14[C12N]
2014/0289,880 TRANSGENIC CHICKENSAbandonedMar 07, 14Sep 25, 14[C07K]
2014/0237,633 GERMLINE TRANSMISSION OF AVIAN PRIMORDIAL GERM CELLS (PGCS)AbandonedJan 24, 14Aug 21, 14[C12N, A01K]
2014/0206,849 ANTIBODIES HAVING REDUCED IMMUNOGENICITY IN A HUMANAbandonedApr 29, 11Jul 24, 14[C07K]
2014/0154,774 NPP1 FUSION PROTEINSAbandonedSep 15, 11Jun 05, 14[C12N]
2014/0127,812 LONG-TERM CULTURE OF AVIAN PRIMORDIAL GERM CELLS (PGCS)AbandonedDec 12, 13May 08, 14[C12N]
2013/0273,052 POLYPEPTIDES THAT BIND TO HUMAN COMPLEMENT COMPONENT C5AbandonedSep 30, 11Oct 17, 13[A61K, C07K]
2013/0276,153 Production of Transgenic Avians Using Improved Retroviral VectorsAbandonedJan 22, 13Oct 17, 13[C12N]
2013/0209,436 LYSOSOMAL STORAGE DISEASE ENZYMESAbandonedApr 23, 11Aug 15, 13[A61K, C12N]
2013/0045,192 REAGENTS AND METHODS FOR DETECTING PNH TYPE II WHITE BLOOD CELLS AND THEIR IDENTIFICATION AS RISK FACTORS FOR THROMBOTIC DISORDERSAbandonedNov 09, 10Feb 21, 13[A61K, G01N, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.